Voximetry Named Finalist for 2025 Siemens Healthineers Startup Award – Recognition highlights innovation and global healthcare impact
Madison, WI – Voximetry, a pioneer in advanced Radiopharmaceutical Therapy (RPT) dosimetry software and services, has been named a finalist for the prestigious Siemens Healthineers 2025 Startup Award. The nomination recognizes Voximetry’s pioneering role in healthcare innovation and its collaborative success as a Siemens Healthineers partner. Launched in 2023, the Siemens Healthineers Startup Award honors […]
Medpace and Voximetry Announce Strategic Partnership to Drive Excellence in Clinical Trials for Pharmaceutical Development.
Cincinnati, OH – Medpace Core Laboratories, a global full-service core laboratory, and Voximetry, a leader in advanced Radiopharmaceutical Therapy (RPT) dosimetry software and services, today announced a strategic partnership aimed at enhancing radiopharmaceutical clinical trials through the integration of cutting-edge dosimetry technology and comprehensive CRO services. Through this agreement, Medpace has designated Voximetry as a […]
Voximetry Announces Preferred Provider Agreement with Y-mAbs Therapeutics for Advanced Dosimetry Services to Support Radiopharmaceutical Development
MADISON, Wis. – Voximetry, a pioneer in advanced dosimetry technology to enable personalized treatments for cancer patients, has finalized a preferred provider agreement with Y-mAbs Therapeutics, a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radiopharmaceuticals, and commercial-stage antibody-based therapeutic products for the treatment of cancer. Through this agreement, Y-mAbs designates Voximetry […]
Dr. Sue Wallace, CEO of Voximetry, Appointed to University of Wisconsin Department of Medical Physics Board of Visitors
MADISON, Wis. – Voximetry, a pioneer in advanced dosimetry technology to enable personalized treatments for cancer patients, proudly announces that its Chief Executive Officer, Dr. Sue Wallace, has been invited to join the University of Wisconsin-Madison Department of Medical Physics Board of Visitors. The Board of Visitors plays a pivotal role in guiding and supporting […]
Voximetry Selected to Provide Torch® Software in Support of FNIH Biomarkers Consortium Initiative to Establish Dosimetry as an Imaging Biomarker
MADISON, Wis. – Voximetry, a pioneer in advanced dosimetry technology to enable personalized treatments for cancer patients, announced today its support for the Foundation for the National Institutes of Health (FNIH), working to establish dosimetry as an imaging biomarker. The Precision Dosimetry Imaging Biomarker (PDIB) project will establish dosimetry as a valuable imaging biomarker to […]
Voximetry Adds Experienced Executive Leader to Oversee Growth of RPT Dosimetry Services
MADISON, Wis. – Voximetry, a pioneer in advanced technology to enable personalized treatments for late–stage cancer patients, has appointed Paul McCracken, PhD as Vice President of Dosimetry Services. In this role Dr. McCracken will lead growth of Voximetry’s clinical and pharmaceutical development services business units. Paul brings over 20 years of experience in imaging and pharmaceuticals, providing […]
Principal Author of OLINDA/EXM Software Joins Voximetry as Dosimetry Scientific Advisor.
MADISON, Wis. – Voximetry, a pioneer in advanced technology to enable personalized treatments for late-stage cancer patients, announced the addition of Dr. Michael Stabin as a key advisor, a move that underscores its commitment to advancing radiopharmaceutical dosimetry solutions. With an extensive background in health physics and nuclear engineering, Dr. Stabin brings over four decades of experience in […]
Voximetry Receives MDSAP Certification to Advance Market Readiness for Australia and Canada.
MADISON, Wis. – Voximetry, a pioneer in advanced technology to enable personalized treatments for late-stage cancer patients, announced today that it has received a Medical Device Single Audit Program (MDSAP) Certificate. This brings Voximetry one step closer to market clearance for clinical use of Torch Dose Assessment software in Canada and Australia. “Access to new […]
Voximetry Chief Executive Recognized for Outstanding Business Achievement in BioHealth.
MADISON, Wis. – Voximetry, a pioneer in advanced technology to enable personalized treatments for late-stage cancer patients, announced today that its CEO, Dr. Sue Wallace received the BioForward Wisconsin 2024 Business Achievement Award. The award recognizes outstanding lifetime leadership contributing to Wisconsin’s economic development and growth. Since 2015, BioForward has been honoring outstanding scientific and […]
Voximetry Poised for Global Expansion with the Appointment of General Manager and CE Mark for EMEA and APAC Commercialization.
MADISON, Wis. – Voximetry, a pioneer in advanced technology to enable personalized treatments for late-stage cancer patients, has appointed Andreas Schulte as General Manager – EMEA/APAC regions. Mr. Schulte has more than 30 years of experience in business and market development in radiation therapy and nuclear medicine. Most recently, Schulte advised various clinical operators in […]